Contineum Therapeutics, Inc. Class A Stock Performance
as on September 4, 2026 at 2:12 am IST
Day's Low
$17.03$17.54
2.91%
Downside
52 Week's Low
52 Week's High
$8.60$17.5150.97%
Downside
-0.17%
Upside
Contineum Therapeutics, Inc. Class A share price movements today
- Previous Close
- $17.24
- Open
- $17.29
- Volume
- 34.6K
- Market Cap
- $622.6M
- Day's Low - High
- $17.03 - $17.54
- 52 Week Low - High
- $8.60 - $17.51
Contineum Therapeutics, Inc. Class A Historical Returns
- 1 Month Return
- + 6.84 %
- 3 Month Return
- + 33.68 %
- 1 Year Return
- + 48.16 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Contineum Therapeutics, Inc. Class A Stock Fundamentals & Key Indicators
Check Contineum Therapeutics, Inc. Class A market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$622.6M
EPS (TTM)
-1.73
Dividend Yield
0.00%
PE Ratio (TTM)
-8.84
Industry PE ratio
-6.724375
PEG Ratio
-0.3690008612786142
Return On Equity TTM
-24.73%
Contineum Therapeutics, Inc. Class A Stock Valuation
Track how Contineum Therapeutics, Inc. Class A P/E has moved over time to understand its valuation trends.
Contineum Therapeutics, Inc. Class A in the last 5 years
Lowest (-15.96x)
December 31, 2022
Industry (-6.72x)
December 31, 2025
Today (-5.27x)
December 31, 2025
Highest (17.13x)
December 31, 2023
Today’s Price to Earnings Ratio: -5.27x
Contineum Therapeutics, Inc. Class A vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Contineum Therapeutics, Inc. Class A with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $622.6M | NA | -8.84 | 0.00% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $137.9B | 174.9% | 31.92 | 86.04% | NA | |
| BUY | $61.6B | -61.21% | -7.98 | -12.57% | NA | |
| BUY | $82.3B | 21.91% | 19.9 | 84.86% | 0.44% |
Stock Returns calculator for Contineum Therapeutics, Inc. Class A Stock including INR - Dollar returns
The Contineum Therapeutics, Inc. Class A stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Contineum Therapeutics, Inc. Class A investment value today
Current value as on today
₹1,68,442
Returns
₹68,442
(+68.44%)
Returns from Contineum Therapeutics, Inc. Class A Stock
₹57,028 (+57.03%)
Dollar Impact
₹11,414 (+11.41%)
Analyst Recommendation on Contineum Therapeutics, Inc. Class A Stock
Based on 6 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 6 analysts, 83.33333333333334% of analysts recommend a 'BUY' rating for Contineum Therapeutics, Inc. Class A. Average target price of $23.8
Indian Investors' Interest in Contineum Therapeutics, Inc. Class A Stock
Search interest for Contineum Therapeutics, Inc. Class A Stock has decreased by -80% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Contineum Therapeutics, Inc. Class A Quarterly Profit & Loss
All numbers in Millions USD
Contineum Therapeutics, Inc. Class A Annual Profit & Loss
All numbers in Millions USD
Contineum Therapeutics, Inc. Class A Quarterly Cash Flow
All numbers in Millions USD
Contineum Therapeutics, Inc. Class A Annual Cash Flow
All numbers in Millions USD
Insights on Contineum Therapeutics, Inc. Class A
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, CTNM stock has moved up by 38.1%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 527.1% return, outperforming this stock by 464.2%
About Contineum Therapeutics, Inc. Class A
| Organisation | Contineum Therapeutics, Inc. Class A |
| Headquarters | 3565 General Atomics Court, San Diego, CA, United States, 92121 |
| Industry | Biotechnology |
| CEO | Mr. Carmine N. Stengone MBA, MS |
| E-voting on shares | Click here to vote |
Key Management of Contineum Therapeutics, Inc. Class A
Name | Title |
|---|---|
Ms. Morgan Paulsen | Senior Manager of Accounting |
Dr. Daniel S. Lorrain Ph.D. | Chief Science Officer |
Mr. John S. Healy | General Counsel & Corporate Secretary |
Ms. Julie S. Iwashita | Senior Vice President of Clinical Operations |
Mr. Carmine N. Stengone MBA, MS | President, CEO & Director |
Mr. Peter T. Slover CPA | Chief Financial Officer |
Dr. Timothy R. Watkins M.D., M.Sc. | Chief Medical Officer & Head of Development |
Mr. Steve E. Kunszabo | Senior Director of Investor Relations & Corporate Communications |
Mr. Austin Chen Ph.D. | Senior VP & Head of Research |
Ms. Kristina Haeckl Rac | Senior Vice President of Regulatory Affairs |
FAQs
What is Contineum Therapeutics, Inc. Class A share price today?
Contineum Therapeutics, Inc. Class A share price today is $17.54 as on . Contineum Therapeutics, Inc. Class A share today touched a day high of $17.54 and a low of $17.03.
What is the 52 week high and 52 week low for Contineum Therapeutics, Inc. Class A share?
Contineum Therapeutics, Inc. Class A share touched a 52 week high of $17.51 on and a 52 week low of $8.60 on . Contineum Therapeutics, Inc. Class A stock price today i.e. is trending at $17.54,which is -0.17% down from its 52 week high and 103.95% up from its 52 week low.
What is Contineum Therapeutics, Inc. Class A's market capitalisation today?
Contineum Therapeutics, Inc. Class A market capitalisation is $0.00T as on .
How to invest in Contineum Therapeutics, Inc. Class A Stock (CTNM) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Contineum Therapeutics, Inc. Class A on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Contineum Therapeutics, Inc. Class A Shares that will get you 0.0855 shares as per Contineum Therapeutics, Inc. Class A share price of $17.54 per share as on September 3, 2026 at 8:42 pm IST.
What is the minimum amount required to buy Contineum Therapeutics, Inc. Class A Stock (CTNM) from India?
Indian investors can start investing in Contineum Therapeutics, Inc. Class A (CTNM) shares with as little as ₹94.475 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in Contineum Therapeutics, Inc. Class A stock (as per the Rupee-Dollar exchange rate as on ).
Based on Contineum Therapeutics, Inc. Class A share’s latest price of $17.54 as on September 3, 2026 at 8:42 pm IST, you will get 0.5701 shares of Contineum Therapeutics, Inc. Class A. Learn more about
fractional shares .